Full Text (PDF)
Journal of Hospital Administration 6(1):p 21-24, January-June 2022. | DOI: NA
Review Article
Post-Covid Prophylaxis in Adults: A Systematic Review
Anjum Abbasi, Ujjwal Sharma, KM Joyti, S P Subashini
Author Information
Licence:
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
Journal of Hospital Administration 6(1):p 21-24, January-June 2022. | DOI: NA
How Cite This Article:
Ujjwal Sharma, KM Joyti, Anjum Abbasi, et al./Post-Covid Prophylaxis in Adults: A Systematic Review/RFP Journal of Hospital Administration. 2022;6(1):21-24.Timeline
Received : March 07, 2022
Accepted : May 24, 2022
Published : June 30, 2022
Abstract
The COVID-19 pandemic has resulted in a growing population of individuals with a wide range of persistent symptoms after acute SARS-CoV-2 infection. This comprises patients with symptoms that develop during or after COVID-19, continue for ≥4 weeks, and are not explained by an alternative diagnosis. Several terms have been used to describe prolonged symptoms following COVID-19 illness, such as "post-COVID conditions," "long COVID," "post-acute sequelae of SARS-CoV-2 infection (PASC)," "post-acute COVID-19," "chronic COVID-19," and "post-COVID syndrome." Whether the constellation of symptoms represents a new syndrome unique to COVID-19 or if there is overlap with the recovery from similar illnesses has not been determined.While most patients with mild acute COVID-19 disease are expected to recover quickly (e.g., two weeks), a longer recovery should be expected in those with moderate to severe acute disease (e.g., two to three months, sometimes longer in those who survive critical illness). The wide variability in time to symptom resolution likely also depends upon premorbid risk factors as well as illness severity during acute COVID-19.During the initial follow-up evaluation, we obtain a comprehensive history of the patient's COVID-19 illness, including the illness timeline, duration and severity of symptoms, types and severity of complications, COVID-19 testing results, and any management strategies. The need for laboratory testing is determined by illness severity, prior abnormal testing during their illness, and current symptoms. We do not routinely re-test patients for active infection with SARS-CoV-2 at the time of follow-up outpatient evaluation. Instead, we follow a non-test-based approach to removing infectious precaution.
References
- 1. https://www.covid19treatmentguidelines.nih. gov/overview/prevention-of-sars-cov-2/
- 2. https://trialsjournal.biomedcentral.com /articles/10.1186/s13063-021-05134-7
- 3. https://clinicaltrials.gov/ct2/show/NCT04308668
- 4. https://www.fda.gov/drugs/drug-safety-andavailability/fda-authorizes-regen-cov-monoclonalantibody-therapy-post-exposure-prophylaxisprevention-covid-19
- 5. https://www.uptodate.com/contents/covid-19-evaluation-and-management-of-adults-followingacute-viral-illness
- 6. https://www.uptodate.com/contents/covid-19-hypercoagulability
Data Sharing Statement
There are no additional data available. All raw data and code are available upon request.
Funding
This research received no funding.
Author Contributions
All authors contributed significantly to the work and approve its publication.
Ethics Declaration
This article does not involve any human or animal subjects, and therefore does not require ethics approval.
Acknowledgements
We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.
Conflicts of Interest
No conflicts of interest in this work.
About this article
Cite this article
Ujjwal Sharma, KM Joyti, Anjum Abbasi, et al./Post-Covid Prophylaxis in Adults: A Systematic Review/RFP Journal of Hospital Administration. 2022;6(1):21-24.
Licence:
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
| Received | Accepted | Published |
|---|---|---|
| March 07, 2022 | May 24, 2022 | June 30, 2022 |
DOI: NA
Keywords
ProphylaxisEpidemicSteam InhalationSearch for Similar Articles
Similar Articles
- Cardiac Complication of Extrapulmonary Tuberculosis
- Quantitative Study to Analyze the Discharge process among IP Patients in Sun Med...
- Transformation of Indian Healthcare Market from Reactive Service Model to a Pro...
- Examining The LASI Data on Mental Health among the Ageing Population: A Comparat...
- Assessing and Improving Early Patient Assessment Documentation: A Quality Improv...
Article Level Metrics
Last UpdatedSunday 04 October 2026, 04:50:28 (IST)
1117
Accesses
1
138
00
Citations
NA
NA
NA
Download citation
Article Keywords
Keyword Highlighting
Highlight selected keywords in the article text.
Timeline
| Received | March 07, 2022 |
| Accepted | May 24, 2022 |
| Published | June 30, 2022 |
licence
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
